BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Will open source biotechnology benefit the bottom billion?  - Jenn
 y Molloy (OpenPlant and Synthetic Biology Strategic Research Initiative) &
  Lalitha Sundaram (Department of Pathology) 
DTSTART:20151111T120000Z
DTEND:20151111T140000Z
UID:TALK62470@talks.cam.ac.uk
CONTACT:Centre For Global Equality
DESCRIPTION:*Speaker:* Jenny Molloy (OpenPlant and Synthetic Biology Strat
 egic Research Initiative)\n*Respondent:* Lalitha Sundaram (Department of P
 athology)\n\n*These are some of the issues Jenny will address:*\nOpenness 
 has developed as a paradigm and movement in fields like government and sci
 ence over the last decade\, building on successes of open source models in
  software. Biotechnology is historically a sector where proprietary techno
 logies and multinational corporations have dominated\, but there is a grow
 ing interest in opening up the tools and technologies necessary to develop
  biotechnological solutions in agriculture\, health\, bioremediation and m
 ore. This is particularly true in the emerging field of synthetic biology\
 , which takes an engineering approach to biological innovation and has alr
 eady delivered yeast producing anti-malarial compounds\, bacterial arsenic
  biosensors and sterile mosquitoes. What does openness mean in synthetic b
 iology and is it achievable from the lab to the field? Will open really en
 able equal access and democratisation of biotechnology to solve local prob
 lems or will the same power structures be maintained?\n
LOCATION:Seminar Room SG2\, Alison Richard Building
END:VEVENT
END:VCALENDAR